8|0|Public
5000|$|... #Caption: Drugstore-made ~400 mL aqueous {{solution}} of Furacilin (<b>nitrofural),</b> 1 : 5000 (0.2 mg/mL or 0.02%), ready for topical use.|$|E
50|$|<b>Nitrofural</b> (INN, {{trade name}} Furacin) is a {{bactericidal}} compound {{used as an}} antibiotic most commonly {{in the form of}} ointments. Its use in medicine has become less frequent as safer and more effective products have become available, and it has been discontinued in the US. The substance is pale yellow and crystalline.|$|E
40|$|SummaryBackgroundCatheter-associated {{urinary tract}} {{infection}} (CAUTI) is a major preventable cause of harm for patients in hospital. We aimed to establish whether short-term routine use of antimicrobial catheters reduced risk of CAUTI compared with standard polytetrafluoroethylene (PTFE) catheterisation. MethodsIn our parallel, three group, multicentre, randomised controlled superiority trial, we enrolled adults (aged ≥ 16 years) requiring short-term (≤ 14 days) catheterisation at 24 hospitals in the UK. Participants were randomly allocated 1 : 1 : 1 with a remote computer allocation to receive a silver alloy-coated catheter, a nitrofural-impregnated catheter, or a PTFE-coated catheter (control group). Patients undergoing unplanned catheterisation were also included and consent for participation was obtained retrospectively. Participants and trial staff were unmasked to treatment assignment. Data were collected by trial staff and by patient-reported questionnaires for 6 weeks after randomisation. The primary outcome was incidence of symptomatic {{urinary tract infection}} for which an antibiotic was prescribed by 6 weeks. We postulated that a 3 · 3 % absolute reduction in CAUTI would represent sufficient benefit to recommend routine use of antimicrobial catheters. This study is registered, number ISRCTN 75198618. Findings 708 (10 %) of 7102 randomly allocated participants were not catheterised, did not confirm consent, or withdrew, and {{were not included in}} the primary analyses. Compared with 271 (12 · 6 %) of 2144 participants in the control group, 263 (12 · 5 %) of 2097 participants allocated a silver alloy catheter had the primary outcome (difference − 0 · 1 % [95 % CI − 2 · 4 to 2 · 2]), as did 228 (10 · 6 %) of 2153 participants allocated a <b>nitrofural</b> catheter (− 2 · 1 % [− 4 · 2 to 0 · 1]). Rates of catheter-related discomfort were higher in the <b>nitrofural</b> group than they were in the other groups. InterpretationSilver alloy-coated catheters were not effective for reduction of incidence of symptomatic CAUTI. The reduction we noted in CAUTI associated with nitrofural-impregnated catheters was less than that regarded as clinically important. Routine use of antimicrobial-impregnated catheters is not supported by this trial. FundingUK National Institute for Health Research Health Technology Assessment Programme...|$|E
40|$|For chronic {{wounds to}} become {{primarily}} healing wounds, {{not only the}} appropriate surgical procedure - especially wound debridement - but also {{the treatment of the}} causative basic disease must be taken into consideration. In both the prophylaxis of wound infections and the treatment of existing wound infections, wound antiseptics play a crucial role. As long as a clinically manifest infection is confined to the wound and has not spread hematogenically, the indication for application of wound antiseptics is given. Should systemic involvement exist, antimicrobial chemotherapy is additionally required. Antiseptics must only be used following careful determination of indication. Impaired wound healing can otherwise result. For chronically poorly healing wounds and burns, polihexanide is the agent of first choice. However, based on new in-vitro findings, octenidine dihydrochloride is superior to polihexanide in terms of therapeutic spectrum. These findings enable a broader application of octenidine dihydrochloride to include use on chronic wounds at lower concentrations than usual. The following agents must be viewed critically in terms of their use as wound antiseptics: chlorhexidine, 8 -chinolinol, <b>nitrofural,</b> phenol derivates, quats, silver nitrate, silver sulphadiazine, tosylchloramide sodium, triclosan, and hydrogen peroxide. As wound antiseptics, dyes and organic mercury compounds are obsolete...|$|E
40|$|The study {{examined}} the effectiveness of sea water hypertonic solution (Aqua Maris troath and oral cavity spray, Jadran, Croatia) medication to treat chronic tonsillitis of the compensated form on 84 children aged between 5 and 15. All children had their tonsil lacunae rinsed in a day № 6 – 8. 64 children had them rinsed with the sea water hypertonic solution (main group), while 20 children had them rinsed with the <b>nitrofural</b> solution (comparison group). Treatment effectiveness was determined according to dynamics of main symptoms (odynophagia, dysphagia, hyperemia and mucosa infiltration of pillars of the fauces), {{as well as the}} degree of tonsil bacterial number before and after treatment (by the 14 th day). The dynamic analysis of subjective data during treatment revealed more significant and positive changes among the children of the main group if compared with patients from the comparison group. After treatment the researchers noticed reduction of tonsil bacterial number among 90, 62 % of children from the main group, whereas this rate made up 60 % in the comparison group. Acquired data allowed recommending this medication for the multimodality therapy of infant adenoid disease. Key words: chronic tonsillitis, treatment, children, sea water hypertonic solution. </p...|$|E
40|$|Rationale: The {{problem of}} the {{resistance}} of microorganisms to many classes of antimicrobial agents becomes increasingly threatening. This promotes the search of new formulations for prevention and treatment of infectious inflammation. Aim: To evaluate antibacterial effects of silver nanoparticle colloid solutions on gram-negative, gram-positive and fungal microflora compared to already known formulations based on silver salts and nitrates of other metals. Materials and methods: The effects of silver nanoparticle colloid solutions (with concentration of nanoparticles of 50 and 100 mg/mL, particle diameter of 15 ± 5 nm) on the microorganism growth were studied in Staphylococcus aureus (#  209 P), Escherichia coli (#  26941), Klebsiella pneumoniae (#  43062) and clinical isolates of Candida albicans. For comparison, silver proteinate, <b>nitrofural,</b> and solutions of NaNO₃, Sn(NO₃) ₂, Co(NO₃) ₂ and Zn(NO₃) ₂ at equimolar concentrations to AgNO₃ 1 % were used. Results: After the plates with test cultures were treated with silver nanoparticle solutions and with comparator solutions, there was sheer culture growth {{in the areas of}} silver nanoparticle application (at both concentrations) and no growth in the areas of the comparator solutions application. Conclusion: The results obtained indicate that silver nanoparticle colloid solutions 50 and 100 mg/mL do not influence the growth of the studied cultures, whereas the comparator solutions exert an advanced antibacterial effect...|$|E
40|$|A doença de Chagas é endemia que afeta grande parte da América Latina. Estima-se que de 18 a 20 milhões de pessoas estejam infectadas pelo parasita causador da doença e que ocorram, aproximadamente, 50. 000 mortes relacionadas à doença de Chagas por ano, nos 21 países da área endêmica. O arsenal terapêutico atualmente usado contra a parasitose, constituído por apenas dois fármacos, é insuficiente, considerando-se, também, que ambos não apresentam ação adequada na fase crônica da doença. Em razão de se tratar de parasitose que acomete apenas países em desenvolvimento, o interesse na pesquisa de novos antichagásicos é consideravelmente baixo por parte dos países que se destacam na introdução de novos fármacos na terapêutica. Resta aos países envolvidos a procura por novas alternativas quimioterápicas. Face ao exposto e ante à alta atividade, em testes {{in vitro}} contra o Trypanosoma cruzi, do derivado hidroximetilado do <b>nitrofural,</b> intermediário de síntese de bases de Mannich, obtido em trabalhos anteriores, o objetivo do presente projeto foi sintetizar bases de Mannich desse derivado com aminoácidos lisina e arginina e o dipeptídio lisina-arginina resultante. Os compostos foram sintetizados utilizando-se métodos clássicos e alternativos e grupos protetores, normalmente utilizados na síntese de peptídios e outros, tentativamente empregados, como os grupos metílico e etílico. Em adição, experimentos foram efetuados com o objetivo de otimizar a síntese do hidroximetilnitrofural. Os derivados sintetizados foram analisados por IV, RMN 1 H e 13 C, e alguns deles, também, por espectrometria de massas. Eles serão submetidos a testes in vitro em cultura de células infectadas com T. cruzi tão logo os grupos protetores sejam removidos. Além disso, serão efetuados testes de liberação para estudo da respectiva estabilidade. Dessa forma, esperam-se obter subsídios importantes para estudos mais aprofundados do seu mecanismo de ação e da possível mutagenicidade envolvida. Chagaś disease is an endemic disease that aftects most part of Latin Arnerica. About 18 to 20 {{million people are}} {{infected}} by the parasite and around 50 thousand deaths are related to Chagasd́isease each year, in the 21 countries of endemic areas. The therapeutic armamentarium available against the disease is constituted by only two drugs and is insufficient, considering, also, that the drugs are not efficient in the chronic phase of the disease. As a parasitosis that only occurs in developing countries, the interest in the research for new antichagasic agents is considerably low in countries {{that are responsible for}} the introduction of new drugs in the therapeutics. So, the search for new chemotherapeutic alternatives is a task for the involved countries. In view of the situation and taking into account the high activity in in vitro tests against Trypanosoma cruzi showed by nitrofurazone hydroxymethyl derivative, an intermediary of Mannich bases reaction previously synthesized, the objective of this work was to synthesize its Mannich bases. The carriers used were aminoacids lysine and arginine and its dipeptide, lysinearginine. The compounds were synthesized using classic and alternative methods and protecting groups, currently used in peptide synthesis and others temptatively employed, as methyl and ethyl groups. Also, many experiments were performed in order to achieve the optimization of hydroxymethylnitrofurazone synthesis. The derivatives synthesized were analyzed by IR, 1 H and 13 C NMR, and some also by mass spectrometry. They will be submitted to in vitro tests with cell infected with T. cruzi as soon as the protecting groups are removed. Besides, tests of drug release will be performed to study their stability. We expect to obtain important information toward better comprehension of their mechanism of action and possible mutagenicity involved...|$|E
40|$|A doença de Chagas é uma doença negligenciada, endêmica, causada pelo protozoário Trypanosoma cruzi, parasita intracelular obrigatório, que necessita de {{seres vivos}} de duas classes totalmente diferentes (insetos, o mais comum, Triatoma infestans, e mamíferos, como, por exemplo, o homem) para completar seu ciclo. Em 2009, a doença completou 100 anos de conhecimento pela humanidade, no entanto não há motivos para comemoração, uma vez que, apesar de quase totalmente descrita desde sua descoberta por Carlos Chagas, não há um fármaco que seja ativo na fase crônica. Sabendo que a fase aguda é de difícil diagnóstico e devido à ausência de sintomas indicativos, pode-se dizer que a doença de Chagas é praticamente incurável. Os fármacos utilizados na terapêutica, benznidazol e nifurtimox, são os mesmos há várias décadas. É, portanto, imperioso se buscar candidatos a fármacos antichagásicos que possam suprir o arsenal terapêutico altamente escasso da parasitose. O hidroximetilnitrofural (NFOH), derivado sintetizado em nosso laboratório, se mostrou antichagásico promissor, com maior atividade in vitro em relação ao benznidazol, além de ser quatro vezes menos tóxico que o <b>nitrofural,</b> seu precursor. Por outro lado, o bioisosterismo {{consiste}} na substituição de elementos ou grupos a fim de se obter melhores propriedades biológicas do fármaco protótipo, caracterizando-se, assim, como forma de modificação molecular. Assim sendo, o objetivo do presente trabalho foi a aplicação de bioisosterismo no anel furânico do NFOH, sintetizando derivados imidazólicos e triazólicos, além do mesmo tipo de modificação molecular na cadeia lateral, através da formação de semicarbazonas e tiossemicarbazonas. Dessa forma, pretendeu-se sintetizar compostos que atuariam sobre o parasita por três diferentes vias: a geração de peróxido de hidrogênio, tóxico por ser dificilmente reduzido pelo parasita, através de reações de oxidorredução mediadas pelo grupo nitro; a inibição da enzima cruzaína (presente somente no Trypanosoma cruzi) e inibição da 14 -&# 945; esterol desmetilase, enzima fundamental na cascata de reações de formação de ergosterol, componente da parede celular do parasita. A síntese dos imidazóis, prevista para ser realizada em cinco ou seis etapas (há possibilidade de realizar em dez etapas através de outra rota), teve duas etapas completadas, com a proteção, utilizando tritila, do nitrogênio 1 do 4 -carboxialdeído imidazol e a produção do agente nitrante. Houve problemas na proteção do hidrogênio ligado à carbonila do mesmo composto, necessária para o êxito da nitração ao carbono 2, seguida de reação de acoplamento com a semicarbazona (e tiossemicarbazona) e hidroximetilação. No caso da síntese dos triazóis, também prevista para ser realizada em cinco etapas, concluíram-se duas delas - oxidação do grupo amina a nitro do 3 -aminotriazol e hidroximetilação no nitrogênio 1, utilizando formaldeído. A etapa seguinte, de oxidação e formação da carbonila, a fim de permitir reação com semicarbazona, não foi bem-sucedida, uma vez que o composto não se mostrou estável nas condições da reação. Tentativas com diferentes métodos foram realizadas, mas não houve sucesso na formação da carbonila ligada ao nitrogênio 1. Análogos do <b>nitrofural</b> contendo anéis nitrobenzênicos e imidazólicos (sem nitro) foram sintetizados e poderão ser ensaiados no prosseguimento deste trabalho. Através de Modelagem Molecular, realizou-se avaliação comparativa entre a capacidade de redução do grupo nitro dos quatro compostos propostos no projeto em relação aos análogos já sintetizados e conhecidos (contendo anel furânico e tiofênico), além de outros catorze compostos propostos contendo mudanças no anel aromático e na semicarbazona/tiossemicarbazona. Foi possível prever a atividade por um dos mecanismos propostos, que podem estar envolvidos também com toxicidade. Dentre os 22 derivados, o composto imidazólico contendo semicarbazona, que está sendo sintetizado, mostrou-se com maior capacidade de sofrer redução no grupo nitro. Dinâmica molecular associada ao docking foi utilizada como ferramenta a fim de se avaliar o mecanismo de inibição sobre a cruzaína. Assim, selecionaram-se o NFOH, além de outros sete bioisósteros, dentre eles os quatro que foram propostos neste projeto. Após dinâmica molecular de 3 ns, observou-se que a CYS 25 da proteína se distanciou da carbonila do NFOH, sugerindo dificuldade ao ataque proposto na literatura para outros compostos contendo esta região da molécula. Estudos adicionais sobre a forma de inibição do NFOH à cruzaína se fazem necessários. Chagasd́isease is an endemic, neglected disease caused by Trypanosoma cruzi protozoan, {{which is an}} intracellular parasite that requires another type of completely different species (insects, the most common, Triatoma infestans and mammals as human being, for example) to complete its cycle. In 2009, this sickness completed 100 years of discovery, however {{there is no reason}} for a happy celebration. In spite of being completely described by Carlos Chagas since that time, there is not even one drug that is active in the chronic phase. As the acute phase is very hard to diagnose, and due to the absence of symptoms, nowadays Chagasd́isease is practically incurable. The drugs used in the therapeutics are the same since decades ago, benznidazole and nifurtimox. So, it is peremptory to find new candidates of antichagasic drugs that may supply the scarce of therapeutic options to this parasitosis. Hydroxymethylnitrofurazone (NFOH), which is already synthesized in our laboratory, has shown to be promising antichagasic with higher activity and four times less toxic in vitro when compared to benznidazole, its precursor. On the other hand, bioisosterism is a useful kind of molecular modification that consists of substitution of elements and groups in order to obtain better biological properties of a prototype. Therefore, the aim of this work was the application of bioisosterism in the furan ring of NFOH by synthesizing imidazole and triazole aromatic ring compounds. Bioisosterism is also applied in the side chain, while semicarbazone and thiosemicarbazone compounds were designed for these possessing nitrogen aromatic rings. So, it was attempted to synthesize compounds that are able to kill the parasite by three different ways: generation of hydrogen peroxide by nitro group, which is highly toxic to the parasite that have problems to neutralize it; inhibition of cruzain, a major cysteine-protease that is present in some catalytic ways of the parasite, and inhibition of 14 -&# 945; sterol demethylase, a fundamental enzyme in the pathway of ergosterol production, which is a cell wall component. In the imidazole synthesis route, two of the five or six steps (there is possibility to achieve in ten steps, by another route), planned were completed, with the trityl protection of the nitrogen 1 of 4 -carboxaldehyde imidazole and the nitrating agent was also produced successfully. Some problems were observed in the protection of the hydrogen bound to the same compound carbonyl by ketal production, which is necessary to provide the nitration in the carbon 2, followed by coupling reaction to the semicarbazide or thiosemicarbazide and the hydroxymethylation, which is the last step of synthesis. In the triazole synthesis, which was predicted to be achieved in five steps, only two were also concluded oxidation of the amino group to produce 3 -nitrotriazole and hydroxymethilation of the nitrogen 1, using formaldehyde. The next step, oxidation to produce carbonyl, in order to allow reaction with the thio or semicarbazone moiety, was not well succeeded, because this compound was not stable in the reaction conditions. Different methods were tempted, but no success was observed for the carbonyl formation on the nitrogen 1. Nitrofurazone (NF) analogs containing nitrobenzenic and imidazolic nucleus (without nitro presence) were synthesized and now are able to be tested in a possible continuation of this work. By using molecular modeling, a comparative evaluation of the nitro reduction capacity by the nitrocompounds designed in this project related with other bioisosters that were already synthesized by our group have been made, in addition to other selected bioisosters. It was possible to predict the activity of these compounds by one of the proposed mechanisms, which can also be evolved with toxicity. Among the 22 calculated compounds, the imidazole compound with sulfur in the side chain presented higher ability to nitro reduction. Molecular dynamics, associated with docking, was used as a tool in order to evaluate the inhibition mechanism over the cruzain. So, NFOH and seven other bioisosters were chosen. After 3 ns of simulation, it was observed that the CYS 25 residue of the protein was distant to the NFOH carbonyl, suggesting difficulty in the proposed in the literature interaction for other compounds containing the moiety. Additional studies to clarify the inhibition form of NFOH to cruzain are necessary...|$|E

